…ct 1.1 (1.1–1.2) and cerebral atrophy 1.7 (1.7–1.8). The aHR of Parkinson’s disease was WMH 1.1 (1.0–1.2), lacunes 1.1 (0.9–1.2), cortical infarct …
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 222 of 2459…d Androgen Excess Society (AES)) have been proposed to diagnose polycystic ovary syndrome (PCOS). The concordance of these guidelines, along with covaria…
…Hyponatraemia is a well-documented side effect of antiseizure medication (ASM…
…us inflammatory aortitis, including giant cell arteritis (GCA), Takayasu arteritis and clinically isolated aortitis (CIA), represents a less under…
…ead and neck cancer (RR 21.31 (95% CI 4.32 to 105.14), I2=97%), liver cancer (RR 4.07 (95% CI 2.34 to 7.08), I2=94%), cervical cancer (RR 3.…
… ovarian cancer cells, independent of glycaemic status. Chronic insulin exposure remodels tumour cell phenotype through TGF-β/SMAD-depe…
… and to characterize 6 month outcomes in patients with advanced chronic kidney disease (CKD) who were not on renal replacement therapy at baseline in …
…ee patients developed mild injection-site skin rash.Conclusions Inclisiran produced substantial and clinically meaningful reductions in LD…
…dergoing 14-day patch-based ambulatory ECG monitoring following ischaemic stroke or TIA between February 2024 and May 2025 at a tertiary NHS cen…
…y development of metabolic syndrome, type 2 diabetes (T2DM) and cardiovascular disease. The vascular wall is comprised of two key cell types: smooth m…
…PTSD were measured with the Generalised Anxiety Disorder-7, the Patient Health Questionnaire-9 and the Primary Care PTSD Screen for the Diagnostic and Statist…
…ns for addiction treatment and several STI diagnoses (syphilis, gonorrhoea, chlamydia). After moving to Italy, he was referred in January …